GlassScriptPhysician profile
Camille Braswell
NPI 1437208030
$5,324.17
in general payments reported to CMS, 2019-2025
51 companies · $701 in 2025
The $701 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $646 · 2020: $388 · 2021: $877 · 2022: $826 · 2023: $1,110 · 2024: $776 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,586.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,067.33 | 2020-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $382.82 | 2019-2022 | |
| Lilly USA, LLC | $354.39 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $341.63 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $253.05 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $206.46 | 2019-2024 | Gardasil 9, Vaxelis, Gardasil |
| Glaxosmithkline, LLC. | $164.75 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $156.14 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Esperion Therapeutics, INC. | $138.68 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $137.94 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.01 | 2019-2024 | |
| Dexcom, INC. | $135.97 | 2021-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $129.52 | 2019-2024 | Veozah |
| Bausch Health US, LLC | $126.41 | 2021-2023 | Aplenzin |
| Novo Nordisk INC | $120.51 | 2021-2025 | Wegovy, Saxenda, Rybelsus |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camille Braswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.